Inflachromene ameliorates Parkinson's disease by targeting Nrf2-binding Keap1
Article in Chemical Science (March 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Chemical Science (March 2024)
Article in Journal of Rehabilitation Medicine (February 2024)
Article in Frontiers in Neurology (January 2024)